XRAY — DENTSPLY SIRONA Cashflow Statement
0.000.00%
- $2.74bn
- $4.60bn
- $3.79bn
- 49
- 71
- 14
- 42
Annual cashflow statement for DENTSPLY SIRONA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K/A | 10-K/A | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -73 | 411 | -950 | -132 | -910 |
Depreciation | |||||
Amortisation | |||||
Deferred Taxes | |||||
Non-Cash Items | 250 | 68 | 1,445 | 385 | 1,063 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 200 | -143 | -78 | -89 | 95 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | 649 | 657 | 517 | 377 | 461 |
Capital Expenditures | -87 | -142 | -149 | -149 | -180 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -1,019 | -216 | 11 | 60 | -17 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -1,106 | -358 | -138 | -89 | -197 |
Financing Cash Flow Items | -56 | -36 | -21 | -10 | -16 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 476 | -379 | -329 | -307 | -302 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 33 | -99 | 26 | -31 | -62 |